About the News Conference
Leading national infectious disease experts presented final influenza (flu) vaccine coverage data from the 2021-2022 US flu season and discussed the importance of vaccination against flu and pneumococcal disease, particularly among older adults and those with chronic health conditions who are at higher risk for related complications.
Results from a new NFID national survey of US adults were also shared on vaccination attitudes and behaviors, including the impacts of the COVID-19 pandemic, at the 2022 National Foundation for Infectious Diseases (NFID) Influenza/Pneumococcal Disease News Conference on Tuesday, October 4, 2022.
Panelists included: Tamika C. Auguste, MD, ACOG Fellow and Chair, Women’s and Infants’ Services, MedStar Washington Hospital Center; William Schaffner, MD, NFID Medical Director; Patricia (Patsy) A. Stinchfield, RN, MS, CPNP, NFID President (Moderator); Jeb S. Teichman, MD, Retired Pediatrician and Healthcare Executive; and Rochelle P. Walensky, MD, MPH, Centers for Disease Control and Prevention (CDC) Director, with additional expert Alicia M. Fry, MD, MPH, Chief, Epidemiology and Prevention Branch, Influenza Division, CDC.
Press Kit Information
View the conference press release, agenda, panelist bios, as well as related resources below.
Influenza Antivirals Fact Sheet
Shareable fact sheet about influenza (flu) antivirals as a key tool to help manage flu—especially for those at high risk of serious complications
2025 National Survey on Respiratory Diseases
2025 national survey on attitudes and behaviors on flu, RSV, COVID-19, and pneumococcal disease
Treating Flu with Antivirals
Shareable resources to raise awareness about flu antiviral medications to help make you feel better faster, and prevent serious complications like pneumonia
2019 NFID Survey: Attitudes about Influenza and Pneumococcal Disease Prevention
NFID 2019 National Survey on flu and pneumococcal disease
- « Previous
- 1
- …
- 4
- 5
- 6